Cathine
Cathine
Cathine
D-NORPSEUDOEPHEDRINE
Clinical data
Cathine
Routes of Oral
administration
CNS stimulant
Legal status
CA: Schedule IV
doses)
UK: Class C
US: Schedule IV
Identifiers
show
IUPAC name
DrugBank DB01486
ChemSpider 390189
UNII E1L4ZW2F8O
KEGG D07627
ChEBI CHEBI:4109
ChEMBL ChEMBL1412041
CompTox DTXSID50889347
Dashboard (EPA)
Formula C9H13NO
show
SMILES
show
InChI
Chemistry[edit]
Cathine is one of the four stereoisomers of phenylpropanolamine (PPA).
Regulation[edit]
The World Anti-Doping Agency's list of prohibited substances (used for the Olympic
Games among other athletic events) bans cathine in concentrations of over
5 micrograms per milliliter in urine. Cathine is a Schedule III drug under the Convention
on Psychotropic Substances.[5] In the United States, it is classified as a Schedule
IV controlled substance.[6]
In Australia, Cathine is officially a schedule 4 drug prescription only, but is not available
or approved for any medical use.
Pregnancy[edit]
Ephedra, found in many Ephedraceae species, is a Chinese and Western herb that
contains, among other amphetamines, D-norpseudoephedrine. In the National Birth
Defects Prevention Study, which included 18,438 women from 10 states from 1999 to
2003, 1.3% of women reported using ephedra during pregnancy. During the trial, five
cases of anencephaly were born to women who used ephedra, however there was
no statistically significant association to women not using ephedra (odds
ratio 2.8, confidence interval 1.0–7.3).[7]
A small study of 642 participants in Yemen found that among pregnant women who
chewed khat (containing D-norpseudoephedrine) there was no increased risk
of stillbirth or congenital malformations.[8] Among lactating women who chew khat, D-
norpseudoephedrine is found in breastmilk.[9]
See also[edit]
L-Norpseudoephedrine, the enantiomer
Methcathinone
Ephedra sinica ("Ephedra")
Ephedrine
Pseudoephedrine
Methamphetamine